Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S,S) Octahydro 6H Pyrrolo[3,4 b]Pyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Moxifloxacin intermediate offering significant cost reduction and scalable manufacturing capabilities for global pharmaceutical supply chains demanding high purity.
Eliminate high-pressure hydrogenation and resolution steps in Moxifloxacin side chain production. Achieve 99%+ ee and 20-30% yield with simplified process. Reduce costs and supply chain risks for API manufacturing.